Citation Impact
Citing Papers
THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS
1996
Apoptosis in the nervous system
2000 StandoutNature
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells
2005
Inflammation and metabolic disorders
2006 StandoutNature
Advanced glycation and endothelial functions: A link towards vascular complications in diabetes
2004
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
The conflicts between strength and toughness
2011 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products
2001
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
1999
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Ribozyme Targeting of Receptor for Advanced Glycation End Products in Mouse Mesangial Cells
1998
Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases
2000 Nature
Guillain-Barré syndrome
2016 Standout
A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
2008
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
2001
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
1996
Regulated portals of entry into the cell
2003 StandoutNature
The effect of advanced glycation end-product formation upon cell-matrix interactions
1999
Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products
1997
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Induction of synthesis and secretion of interleukin 1β in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation endproducts
1996
Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
1995
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
1998
Nomenclature of the Proteins of Cows’ Milk—Sixth Revision
2004 Standout
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
1996
Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane
1998 Standout
Diabetes and Atherosclerosis
2002 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
1995
Age-related macular degeneration
2018 Standout
Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress
1997
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
RAGE: A New Target for the Prevention and Treatment of the Vascular and Inflammatory Complications of Diabetes
2000
Caveolae: From Cell Biology to Animal Physiology
2002
Fibulin-5/DANCE is essential for elastogenesis in vivo
2002 StandoutNatureNobel
Alzheimer's Disease
2010 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice
2001
Origin and physiological roles of inflammation
2008 StandoutNature
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
The RAGE Axis and Endothelial Dysfunction: Maladaptive Roles in the Diabetic Vasculature and Beyond
2005
Mechanisms of distal axonal degeneration in peripheral neuropathies
2015
Sp1-binding Elements in the Promoter of RAGE Are Essential for Amphoterin-mediated Gene Expression in Cultured Neuroblastoma Cells
1998
Atherogenesis and Advanced Glycation: Promotion, Progression, and Preventiona
1997
Idiopathic pulmonary fibrosis
2011 Standout
Atherosclerosis
2000 StandoutNature
Inflammation and its role in age-related macular degeneration
2016
Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
1993
Frailty in elderly people
2013 Standout
Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways
1999
Molecular mechanisms of ageing in connective tissues
2001
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
Atherosclerosis as disease of redox-sensitive genes.
1998
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
1999 StandoutScience
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans
2002 Standout
The Free Radical Theory of Aging Matures
1998 Standout
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.
1994
Advanced Glycation End Products
2006 Standout
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.
1996
Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.
1994
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
1994
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
2000 Standout
Glycation, Inflammation, and RAGE
2003
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
1998 Standout
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
1992
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE
2002
Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.
1997
Inflammation and Atherosclerosis
2002 Standout
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
Functions of a Chitosan-Orotic Acid Salt in the Gastrointestinal Tract
2003
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
1997
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
2001
RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts
2009
Intracellular Restraint: A New Basis for the Limitation in Response to Oxidative Stress in Human Erythrocytes Containing Low-Activity Variants of Glucose-6-Phosphate Dehydrogenase
1974
Activation of Receptor for Advanced Glycation End Products
1999
ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING
1995
Understanding RAGE, the receptor for advanced glycation end products
2005
The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide
1994
Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
1994
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products
2003
Glucose-6-phosphate dehydrogenase deficiency
2008 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.
1993
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE
1997
Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.
2000
Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex
1995
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells
1997
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
RAGE Axis
2004
Endothelial Function and Dysfunction
2007 Standout
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
2001
Works of H.M. Hegarty being referenced
Electrophoretic Comparisons of Lactoferrin from Bovine Mammary Secretions, Milk Neutrophils, and Human Milk
1993
Orotic Acid in Milks of Various Species and Commercial Diary Products
1979
Pyridine nucleotides in human erythrocytes in different metabolic states
1969
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
1992